<DOC>
	<DOCNO>NCT00481429</DOCNO>
	<brief_summary>Hypothesis : A cluster biochemical measurement ( biomarkers ) predict diabetic patient respond treatment therapeutic dose rosiglitazone 12 week treatment period . Brief Summary : The purpose study assess predictive value biomarkers diabetic patient treat full dose thiazolidinedione ( eg 4mg bid rosiglitazone ) 12 week . Specifically - question ask : 1 . Do baseline measurement select panel biomarkers predict patient ' response rosiglitazone 12 week ? 2 . How panel biomarkers change 12 week treatment period ?</brief_summary>
	<brief_title>Predictive Markers Glitazone Efficacy Diabetic Patients - Pilot Study</brief_title>
	<detailed_description>Rosiglitazone ( Avandia ) medicine use treat type 2 diabetes . It work increase sensitivity body tissue insulin . This pilot study examine possibility baseline biochemistry might predict response rosiglitazone . The study conduct male biomarkers interest measure specific assay . In addition , since biomarkers measure come body fat , interpretation data would facilitate accurate measurement change body fat mass treatment data obtain Echo-MRI scan .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>1 . Male subject age 18 65 year . 2 . Eligible subject must free clinically significant illness disease ( type 2 diabetes ) exception chronic stabletreated hypertension ( BP &lt; 160/90 , &gt; 90/50 ) , thyroid disease ( TSH normal reference range ) and/or dyslipidaemia . 3 . BMI must &gt; = 25kg/m2 &lt; = 40kg/m2 , 4 . HbA1c 7and 10 % , fast blood glucose 7mmol/L ( fast mean great = 8 hour prior screen ) . 5 . On diet alone diet plus metformin ( GSK data indicate latter group faithfully reflect behaviour 'naive ' patient wash prior medication ) least 1 month . 6 . On stable dos antihypertensive medication , thyroid hormone replacement statin therapy require . 1 . Prior treatment thiazolidinedione , insulin GLP1 analogue ( Byetta ) 2 . History hepatic disease , impairment abnormal liver function test i.e . AST , ALT &gt; 2 time upper limit normal range ( ULN ) , bilirubin &gt; 1.5 time ULN . History renal disease serum creatinine great 1.5 X ULN . 3 . Contraindications rosiglitazone treatment . 4 . Serum creatinine great 1.5 X upper limit normal range . 5 . Any clinically significant laboratory abnormality . 6 . Claustrophobic contraindication MRI scan 7 . Females childbearing age unwilling use appropriate method contraception . 8 . Unable give inform consent . 9 . Unable comply study protocol . 10 . Clinically significant comorbidity .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Biomarker</keyword>
	<keyword>Glitazone</keyword>
	<keyword>Diabetes</keyword>
</DOC>